Actual enrollment decreased by 5 participants
Before: 905 participants (actual). After: 900 participants (actual).
Study sponsor: Vaxcyte, Inc. · PCVX
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: 905 participants (actual). After: 900 participants (actual).
Before: Estimated. After: Actual.
Before: 900 participants (planned). After: 905 participants (actual).
Before: Recruiting. After: Active not recruiting.